CVS expects 70%-80% drop in COVID vaccine administration in 2022 By Reuters


© Reuters. FILE PHOTO: People walk by a CVS pharmacy store in Manhattan, New York City, New York, U.S., November 17, 2021. REUTERS/Andrew Kelly/File Photo

(Reuters) – CVS Health Corp (NYSE:) said on Wednesday it expects to administer 70% to 80% fewer COVID-19 vaccines in 2022 compared with last year, adding that in-store diagnostic testing could fall 40% to 50%.

The company administered more COVID-19 vaccine boosters in the fourth quarter instead of the first quarter of 2022, as it had previously expected, executives said on a post-earnings call.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Source link

User Avatar
Tkoinvestor

You may also like

image_1212246344.jpg
AT&T Q1 2022 Earnings Preview: Watch These Developments (NYSE:T)
17 April, 2022
image_1157326018.jpg
Acuity Brands: Trading Near Weakening Support Zone Without M&A Catalysts (NYSE:AYI)
17 April, 2022
image_1072593728.jpg
Dividend Champion, Contender, And Challenger Highlights: Week Of April 17
17 April, 2022

Leave A Reply

Your email address will not be published. Required fields are marked *

X